89 related articles for article (PubMed ID: 26279176)
1. Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances.
Yin Y; Liu Y; Zhuang J; Pan X; Li P; Yang Y; Li YP; Zhao ZQ; Huang LQ; Zhao ZX
Pharmacology; 2015; 96(3-4):155-62. PubMed ID: 26279176
[TBL] [Abstract][Full Text] [Related]
2. Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease.
Mohamed S; Rosenheck R; Lyketsos CG; Kaczynski R; Sultzer DL; Schneider LS
J Clin Psychiatry; 2012 Jan; 73(1):121-8. PubMed ID: 21939611
[TBL] [Abstract][Full Text] [Related]
3. Non-pharmacologic management of sleep disturbance in Alzheimer's disease.
David R; Zeitzer J; Friedman L; Noda A; O'Hara R; Robert P; Yesavage JA
J Nutr Health Aging; 2010 Mar; 14(3):203-6. PubMed ID: 20191254
[TBL] [Abstract][Full Text] [Related]
4. Melatonin and Sleep Disturbances in Alzheimer's Disease.
Prodhan AHMSU; Cavestro C; Kamal MA; Islam MA
CNS Neurol Disord Drug Targets; 2021; 20(8):736-754. PubMed ID: 34348635
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease.
Burke SL; Hu T; Spadola CE; Burgess A; Li T; Cadet T
J Aging Health; 2019 Feb; 31(2):322-342. PubMed ID: 30160576
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease phenotypes show different sleep architecture.
Falgàs N; Walsh CM; Yack L; Simon AJ; Allen IE; Kramer JH; Rosen HJ; Joie R; Rabinovici G; Miller B; Spina S; Seeley WW; Ranasinghe K; Vossel K; Neylan TC; Grinberg LT
Alzheimers Dement; 2023 Aug; 19(8):3272-3282. PubMed ID: 36749893
[TBL] [Abstract][Full Text] [Related]
7. Tone-induced sleep fragmentation in persons with Alzheimer's disease: a feasibility study.
Cole CS; Richards KC; Smith-Olinde L; Roberson PK; Sullivan DH
Biol Res Nurs; 2010 Jan; 11(3):229-35. PubMed ID: 19617235
[TBL] [Abstract][Full Text] [Related]
8. Sleep quality of spousal caregivers is associated with neuropsychiatric symptoms and living ability of patients with Alzheimer disease.
Chen Y; Wang JY; Liu XY; Meng FX; Li AP; Peng GP
Chin Med J (Engl); 2019 Jun; 132(12):1490-1493. PubMed ID: 31205111
[No Abstract] [Full Text] [Related]
9. Editorial: sleep and dementia.
Gabelle A; Dauvilliers Y
J Nutr Health Aging; 2010 Mar; 14(3):201-2. PubMed ID: 20191253
[No Abstract] [Full Text] [Related]
10. Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy.
Wang X; Zhao X; Johnston SC; Xian Y; Hu B; Wang C; Wang D; Liu L; Li H; Fang J; Meng X; Wang A; Wang Y; Wang Y;
Neurology; 2015 Aug; 85(7):573-9. PubMed ID: 26283758
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
[TBL] [Abstract][Full Text] [Related]
12. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
[TBL] [Abstract][Full Text] [Related]
13. Risperidone and Risk of Gynecomastia in Young Men.
Etminan M; Carleton B; Brophy JM
J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):671-3. PubMed ID: 26287371
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic α7 and α4β2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders.
McLean SL; Grayson B; Marsh S; Zarroug SH; Harte MK; Neill JC
Behav Brain Res; 2016 Apr; 302():73-80. PubMed ID: 26327238
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Response to Cholinesterase Inhibitor Treatment Is Related to Functional MRI Response in Alzheimer's Disease.
Miettinen PS; Jauhiainen AM; Tarkka IM; Pihlajamäki M; Gröhn H; Niskanen E; Hänninen T; Vanninen R; Soininen H
Dement Geriatr Cogn Disord; 2015; 40(5-6):243-55. PubMed ID: 26305064
[TBL] [Abstract][Full Text] [Related]
16. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress.
Stella F; Radanovic M; Canineu PR; de Paula VJ; Forlenza OV
Ther Adv Drug Saf; 2015 Aug; 6(4):151-65. PubMed ID: 26301069
[TBL] [Abstract][Full Text] [Related]
17. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
Xu L; Wu X; Chen K; Yao L
Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
[TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
19. Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer's disease: a meta-analysis.
Su J; Liu Y; Liu Y; Ren L
Expert Rev Neurother; 2015; 15(9):1093-103. PubMed ID: 26289489
[TBL] [Abstract][Full Text] [Related]
20. MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol.
Deiana S; Watanabe A; Yamasaki Y; Amada N; Kikuchi T; Stott C; Riedel G
Behav Pharmacol; 2015 Dec; 26(8 Spec No):748-65. PubMed ID: 26287433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
